BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,696 | +25.3% | 481,440 | -18.3% | 0.01% | +33.3% |
| Q2 2023 | $10,134 | -9.2% | 589,164 | -12.5% | 0.01% | +20.0% |
| Q1 2023 | $11,159 | +21.8% | 672,979 | -44.0% | 0.01% | +25.0% |
| Q4 2022 | $9,159 | -99.7% | 1,201,885 | +268.2% | 0.00% | 0.0% |
| Q3 2022 | $3,244,000 | +1110.4% | 326,417 | +1008.8% | 0.00% | – |
| Q2 2022 | $268,000 | -38.0% | 29,438 | -30.9% | 0.00% | – |
| Q1 2022 | $432,000 | -93.3% | 42,586 | -89.0% | 0.00% | -100.0% |
| Q4 2021 | $6,474,000 | +54.3% | 388,148 | +333.4% | 0.00% | -50.0% |
| Q3 2021 | $4,197,000 | +9.2% | 89,566 | +42.1% | 0.00% | 0.0% |
| Q2 2021 | $3,842,000 | -37.8% | 63,020 | -37.1% | 0.00% | -33.3% |
| Q1 2021 | $6,174,000 | +138.2% | 100,219 | +175.0% | 0.00% | +200.0% |
| Q4 2020 | $2,592,000 | +107.0% | 36,448 | +9.2% | 0.00% | 0.0% |
| Q3 2020 | $1,252,000 | -15.6% | 33,372 | -26.6% | 0.00% | 0.0% |
| Q2 2020 | $1,484,000 | +74.4% | 45,488 | +54.9% | 0.00% | 0.0% |
| Q1 2020 | $851,000 | -7.1% | 29,364 | +12.4% | 0.00% | 0.0% |
| Q4 2019 | $916,000 | +211.6% | 26,134 | +90.7% | 0.00% | – |
| Q3 2019 | $294,000 | -37.0% | 13,703 | -20.9% | 0.00% | – |
| Q2 2019 | $467,000 | – | 17,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $100,609,513 | 48.41% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $514,990,899 | 15.50% |
| M28 Capital Management LP | 304,700 | $5,051,926 | 5.71% |
| Cormorant Asset Management, LP | 4,557,414 | $75,562 | 4.98% |
| Octagon Capital Advisors LP | 1,338,160 | $22,186,693 | 3.19% |
| Ikarian Capital, LLC | 594,686 | $9,859,894 | 2.24% |
| Affinity Asset Advisors, LLC | 389,800 | $6,462,884 | 2.13% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $441,376,031 | 2.07% |
| Ikarian Capital, LLC | 549,600 | $9,112,368 | 2.07% |
| Affinity Asset Advisors, LLC | 320,000 | $5,305,600 | 1.75% |